Sign in

Benjamin P. Geisler

@ben-geisler.com
210 followers 425 following 182 posts

Stipendiat in Oslo, 🇳🇴 | prior hospitalist | Stuck between 3 continents/still fresh off the boat | RT≠opinion≠others' www.ben-geisler.com

PostsRepliesMedia
Benjamin P. Geisler @ben-geisler.com · 20h
Rebuilding a health system takes money. Keeping it coordinated across donors and accountable is the harder part. Open lecture at UiO, Wed 7 Oct, 12–13, with Nataliia Kovalenko (health financing expert, Ukraine). Anyone welcome. healtheconomics.no/H...
000
Benjamin P. Geisler @ben-geisler.com · 23/09/2026
This was already in the news - but 👍 to see the paper published: a negative result of a multiple-cancer early detection (MCED) test, GRAIL's Galleri, w/ >70k 🇬🇧 particip. Bottomline: stage shifting didn't work here. ❓is if this is even possible with a blood-based test? www.nejm.org/doi/full/10....
000
Benjamin P. Geisler @ben-geisler.com · 19/09/2026
Etterutdanning: god helseledelse krever økonomisk innsikt - budsjett, ressursbruk, beslutninger under press. HELED holder kurset Økonomi for helseledere til høsten, for ledere i tjeneste og industri. Del 👇
linkedin.com
EVU: Økonomi for helseledere - Institutt for helse og samfunn | Avdeling for helseledelse og helseøkonomi, Universitetet i Oslo
🎓Kurs i økonomi for helseledere ved Avd. for helseledelse og helseøkonomi, UiO 📅PÅMELDINGSFRIST 2. november ⭐Avdeling for helseledelse og helseøkonomi ved UiO tilbyr et etterutdanningskurs i økonomi for helseledere til høsten. ⏱️Kurset går over tre dager: 16.-18. november. Dette er en unik mulighet til å lære grunnprinsippene i hvordan økonomisk styring i helsesektoren faktisk fungerer. Det er også mulighet til å oppdatere seg på faget eller friske opp ting man har glemt fra tidligere! Forelesere er Jan Erik Tveiten, støttet av Bjørn-Atle Reme. Begge er erfarne forelesere innen temaet og får svært gode tilbakemeldinger fra studentene på undervisningen. Se lenken under for mer info og påmelding! Det medisinske fakultet UiO https://lnkd.in/eJfZjwAJ
000
Benjamin P. Geisler @ben-geisler.com · 15/09/2026
Manual data exports: 42.4 per 30 days before TRACE, 4.7 after. Turns out the fix for shadow copies of sensitive health data isn't better rules -- it's not needing the export. Open source, GDPR-shaped, feasibility not effectiveness. Free link: link.springer.com/ar...
000
Benjamin P. Geisler @ben-geisler.com · 11/09/2026
Er et helsetiltak verdt kostnaden? HELED holder etterutdanningskurs i økonomisk evaluering til høsten - for tjenesten, industrien, DMP, FHI. Del 👇
med.uio.no
EVU: Helseøkonomi og økonomisk evaluering
Kurset gir en introduksjon til helseøkonomiske prinsipper for evaluering av helsetiltak, norske prioriteringskriterier, innføring i ulike av beslutningsmodeller og praktiske øvelser i evaluering av tiltak. Du vil lære hva som ligger til grunn for finansieringsbeslutninger av legemidler og ny teknologi i Norge.
000
Reposted by Benjamin P. Geisler
Altmetric @altmetric.com · 08/09/2026
Update: The academic flight from Twitter is now complete and appears permanent. April 2023, after the pandemic research surge, we recorded 2,234,307 posts sharing research on Twitter. As of April this year, "X" had 896,741 posts about research. That's a 60% drop in traffic.
Graph showing cumulative research sharing across platforms, including Twitter - April 2023Graph of April 2026 cumulative research sharing including "X". One third of what it was.
9318136
Benjamin P. Geisler @ben-geisler.com · 26/08/2026
Aimed at DA modelers in health econ: Agentic Coding - The Dark Side of the Moon? www.slideshare.net/s...
110
Benjamin P. Geisler @ben-geisler.com · 24/08/2026
Just finished Deb Cohen's "Bad Influence." Her chat with Eric Topol is a fabulous overview of the book, stories included -- how influencers replaced doctors as our trusted health voice. erictopol.substack.c...
000
Benjamin P. Geisler @ben-geisler.com · 19/08/2026
I worked on the cost side: widen biologic eligibility, exacerbations drop further, but at what price? Current UK criteria cover 1 in 5 severe asthma patients; broader criteria push that 3-6x, at £261M-£1.6B over 5yrs. Free link 👇 www.sciencedirect.co...
000
Benjamin P. Geisler @ben-geisler.com · 13/08/2026
Today, I walked by a banner that indicated that the University of Oslo is hosting the 30th Annual Viking Congress - unclear if for or about 'em.
110
Benjamin P. Geisler @ben-geisler.com · 13/08/2026
Interesting essay: the "junkification" eating e-commerce platforms is now hitting academic publishing too. Pay-to-publish fees up to €9,500, predatory journals, AI filler -> volume beats quality? Real reform proposals, too. journals.sagepub.com...
000
Benjamin P. Geisler @ben-geisler.com · 12/08/2026
New paper in NDT: urea vs. tolvaptan for hospitalized SIADH (n=537). Similar efficacy (~80%), but urea had fewer overcorrections (3.2% vs 10.8%) at €12 vs €468. Cheap and safe wins. academic.oup.com/ndt...
000
Reposted by Benjamin P. Geisler
Our World in Data @ourworldindata.org · 20/07/2026
✍️ New article from @hannahritchie.bsky.social: “How much energy do data centers and artificial intelligence use?” Artificial intelligence is being adopted rapidly across the world, and this is accelerating the demand for data centers that run these models.
Stacked bar chart of projected global electricity use by data centers in 2025 and a base-case projection for 2030, where most of the increase is expected to come from AI-focused data centers. It shows totals rising from 485 TWh (1.5% of global electricity) in 2025 — split into 155 TWh for AI-focused and 330 TWh for non-AI centers — to 945 TWh (3% of global electricity) in 2030 — split into 465 TWh AI-focused and 480 TWh non-AI. Data source: IEA (2026). License: CC BY to Our World in Data.
36633
Benjamin P. Geisler @ben-geisler.com · 03/07/2026
Klopp der neue Klinsi?
000
Benjamin P. Geisler @ben-geisler.com · 03/07/2026
000
Benjamin P. Geisler @ben-geisler.com · 03/07/2026
Wonderful @smdm.bsky.social mtg in Oslo: great to see old friends & meet new ones Loved that people got to experience Oslo Claxton/Philipson debate a highlight as was the warm welcome from the mayor&Ivar at City Hall 👏@emilyannika.bsky.social, @twisloff.bsky.social, teams, & supporters 🙏 #SMDM26
000
Benjamin P. Geisler @ben-geisler.com · 29/06/2026
Attending #SMDM26? Join "Red Team: A.I. for adversarial review" at 07/01/2026 09:30 AM through the Whova event app.
000
Benjamin P. Geisler @ben-geisler.com · 28/06/2026
@smdm.bsky.social -appropriate convention ribbons at #SMDM26:
000
Benjamin P. Geisler @ben-geisler.com · 27/06/2026
Already >1mo. old, but maybe still relevant if you're in global/public health: really interesting BMJ piece on not just the election of the next World Health Organization's Director General - but also, what situation they may find themselves in.. 🩺🌍🌎🌏
bmj.com
Who will be the next leader of the beleaguered WHO?
Amid global disorder and heightened demands for reform, the campaign for the next director general of the world’s health agency is perhaps its most important ever. Jocalyn Clark reports The term of the World Health Organization’s current boss, Tedros Adhanom Ghebreyesus, is coming to an end after a nearly 10 year reign. Given constant political upheavals and unrelenting health crises, you would think no one would want the complex job of leading WHO when his tenure ends in August 2027. But the campaigning for its next director general has already begun, with several notable names, including doctors, rumoured to be in the mix (box 1). Box 1 ### Potential candidates for the next WHO director general Among those reported to be considering candidacy are several WHO staff and regional directors and former government officials, among them doctors:RETURN TO TEXT Formal invitations for candidates for director general were issued on 24 April 2026, as world leaders and global health experts were preparing to gather in Geneva for the annual World Health Assembly which began on 18 May. Between now and election day in May 2027, a shortlist of candidates will be chosen by the executive board members of WHO and, following candidate forums and interviews, all member states will have a secret vote at next year’s …
000
Benjamin P. Geisler @ben-geisler.com · 27/06/2026
Looking forward to @smdm.bsky.social's 2026 meeting to start in beautiful Oslo, 🇳🇴 🌞 🙌 🤗 #SMDM26
000
Reposted by Benjamin P. Geisler
Mark Hamill @markhamillofficial.bsky.social · 21/06/2026
Happy Father's Day 🖤
997420456320
Benjamin P. Geisler @ben-geisler.com · 19/06/2026
New paper in PharmacoEconomics: our systematic review of structured expert elicitation (SEE) in health economic evaluations, 2017–2026. 28 studies. Methods vary widely — standardization & validation urgently needed.
link.springer.com
Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update
PharmacoEconomics - Structured expert elicitation (SEE) has become increasingly important in health technology assessment and economic evaluations. Complementing previous work, we aimed to...
011
Benjamin P. Geisler @ben-geisler.com · 17/06/2026
Catch up on the newest two AI for Dx (and Rx) Nature papers - one in the E.D. and one from a primary care setting:
000
Benjamin P. Geisler @ben-geisler.com · 15/06/2026
New @escardio.bsky.social #ESCCardiotalk episode: Arnab Ghosh and I talk through our European Heart Journal editorial on tropical cyclones and acute coronary syndrome -- a 14% spike in ACS risk post-storm, and what health systems need to do as major cyclones intensify. Links in comments.
200
Benjamin P. Geisler @ben-geisler.com · 15/06/2026
Webinar coming up this week (Thursday, 9am CET) on the role of biomarkers (NGS/genetics and otherwise) in economic evaluation/CEA.. register below
010
Benjamin P. Geisler @ben-geisler.com · 15/06/2026
Will this be monetized, is another question
000
Benjamin P. Geisler @ben-geisler.com · 13/06/2026
Love the follow-up post
010
Reposted by Benjamin P. Geisler
Eric Topol @erictopol.bsky.social · 12/06/2026
For medical information, general AI frontier models (Google, OpenAI, Anthropic) outperformed specialized @openevidence.bsky.social and UptoDate AI Assessed by 12 US clinicians, randomized & model blinded w/extensive testing/benchmarks. This was not anticipated nature.com/articles/s41...
37125
Reposted by Benjamin P. Geisler
Society for Medical Decision Making (SMDM) @smdm.bsky.social · 08/06/2026
Get ready for #SMDM26! @ben-geisler.com is looking forward to: "The Philipson vs. Claxton debate moderated by Sculpher, the DARTH R pre-conference course, and seeing everyone in beautiful Oslo " 🇳🇴 We can't wait to see Ben in Oslo! #MedicalDecisionMaking #SMDM26
011
Benjamin P. Geisler @ben-geisler.com · 06/06/2026
A YouTube commenter once told me all cardiologists lie about statins. Deb Cohen on The @economist.com's Babbage pod explains the mechanism better than I ever could: the nocebo effect, and how influencer culture scales it up. 🎁 link: www.economist.com/podcasts/202...
economist.com
Influencers v evidence-based medicine (part one)
Our podcast on science and technology. In the first of two episodes on health misinformation, Deborah Cohen, doctor and author, tells us how the internet is hijacking health care
010
Benjamin P. Geisler @ben-geisler.com · 03/06/2026
That's not just a laser pointer that fits in between those survival curves.. 🖊️ 🚨
000
Benjamin P. Geisler @ben-geisler.com · 03/06/2026
I'm speaking at ASCERTAIN's June 18 webinar on precision medicine, genetic testing & biomarkers in oncology. NGS economics, HTA & patient value. 9–10am CET 🔬
access2meds.eu
Webinar: How Can Precision Medicine, Genetic Testing, and Biomarkers Support Better Healthcare Decisions?
Webinar: How Can Precision Medicine, Genetic Testing, and Biomarkers Support Better Healthcare Decisions?
000
Benjamin P. Geisler @ben-geisler.com · 29/05/2026
📣 ASCERTAIN Final Conference | Brussels, 21 October 2026: "From Evidence to Access: Rethinking Healthcare Decision-Making in Europe". Join stakeholders for equitable access & sustainable pricing. Register:
access2meds.eu
ASCERTAIN Final Conference
From Evidence to Access: Rethinking Healthcare Decision-Making in Europe. As the ASCERTAIN project comes to an end, we are pleased to announce that our final conference will take place on 21 October 2026 in Brussels.
000
Benjamin P. Geisler @ben-geisler.com · 27/05/2026
The Danish Centre for Health Economics (DaCHE) at University of Southern Denmark is advertising two fully funded PhD positions. More information and application details:
fa-eosd-saasfaprod1.fa.ocs.oraclecloud.com
Declaration of interest regarding PhDs projects on prioritization in health care
The Danish Centre for Health Economics (DaCHE) at the Department of Public Health, Faculty of Health Sciences, University of Southern Denmark is looking for applicant for two full time fully financed PhD positions. Start date is 1st of September 2026 or soon thereafter.
000
Reposted by Benjamin P. Geisler
Eric Topol @erictopol.bsky.social · 24/05/2026
If you're interested in the hot (yet complex) field of cancer immunotherapies with >2,000 approved or in the works, I've done a rundown and future outlook erictopol.substack.com/p/the-remark...
9425114
Benjamin P. Geisler @ben-geisler.com · 18/05/2026
Free chapter from 50 Studies Every #Hospitalist Should Know (@academic.oup.com) -- no login needed, available until June 24. Edited by Geisler, Greenwald & Tran / @harvard.edu. #MedEd #HospitalMedicine academic.oup.com/book/62233/c...
010
Benjamin P. Geisler @ben-geisler.com · 14/05/2026
Here's the chapter on the KevinMD blog: kevinmd.com/2026/03/mana...
kevinmd.com
Managing acute heart failure: evidence from the DOSE trial
DOSE trial heart failure findings guide diuretic dosing. Learn why high-dose bolus furosemide is often preferred over continuous infusion for acute decompensation.
010
Benjamin P. Geisler @ben-geisler.com · 13/05/2026
Tropical cyclones raise heart attack risk by 14% in just 3 days. As climate change intensifies storms, cardiovascular systems -- especially in middle-income countries -- must prepare. New editorial in European Heart Journal 🌀🫀 Guest access link below: academic.oup.com/eur...
020
Benjamin P. Geisler @ben-geisler.com · 12/05/2026
AI can retrieve any guideline instantly. It still can't tell you your patient wasn't in the trial. Talked to KevinMD about this (and a few studies worth actually knowing) with my co-editors: www.youtube.com/watch?v=ep6m...
200
Benjamin P. Geisler @ben-geisler.com · 10/05/2026
Lancet audit of 2.5M papers: nearly 0.6% now contain citations to studies that don't exist. Rate was flat in 2023, then 12-14x'd, right as LLMs went mainstream. LLMs don't necessarily retrieve citations but generate plausible ones. The scientific record has a quiet problem. www.thelancet.com/jo...
000
Benjamin P. Geisler @ben-geisler.com · 05/05/2026
My X feed this morning..
000
Reposted by Benjamin P. Geisler
Society for Medical Decision Making (SMDM) @smdm.bsky.social · 29/04/2026
Get ready for #SMDM26 in Oslo! Pia Henkel is looking forward to: "Getting to know new people and their research during the poster sessions and, of course, welcoming a lot of new and old, friends and contacts to Oslo." 🇳🇴 We are excited to see Pia in Oslo! #SMDM26 Register today! buff.ly/4yUmc0x
001
Benjamin P. Geisler @ben-geisler.com · 15/04/2026
Endpoint Arena bills itself as a prediction market for clinical trials. How do human/AI predictions influence recruitment, early termination, disinvestment? Can we still call it equipoise if a trial is badmouthed? Will there be insider training like on Polymarket? endpointarena.com/
000
Benjamin P. Geisler @ben-geisler.com · 14/04/2026
Inside the £64bn pharma deal that could cost more lives than Covid www.thebureauinvesti... HT: Mark Sculpher
thebureauinvestigates.com
Inside the £64bn pharma deal that could cost more lives than Covid
With the NHS on its knees, the UK has struck a secretive new drugs deal. But how was it made – and what will it really cost?
000
Benjamin P. Geisler @ben-geisler.com · 31/03/2026
At #SHMConverge26? Today's Updates in Hospital Medicine covers the last year. Our book covers the last 20+ years - the evidence beneath the updates. Free chapter (DOSE trial) until April 16: academic.oup.com/boo... 30% discount AUFLY30: academic.oup.com/
000
Benjamin P. Geisler @ben-geisler.com · 27/03/2026
Economists often look to the 🇺🇸. Famously, when America sneezes, the world catches a cold. What's going on in the country in terms of people's attitudes towards wealth? These days, I only travel to the 🇺🇸 x 1-2/year, but found this column worthwhile.
nytimes.com
Opinion | How Can America Be So Miserable When It’s So Rich?
The just resentments of a shrinking middle class.
010
Benjamin P. Geisler @ben-geisler.com · 20/03/2026
The editing team (before years of transatlantic Zoom calls) 🤓 Grateful to every contributor who made this educational product happen 🙏
000
Benjamin P. Geisler @ben-geisler.com · 19/03/2026
50 Studies Every Hospitalist Should Know wouldn't exist without its contributors - hospitalists, cardiologists, ID specialists, intensivists who distilled the trials that shape their bedside decisions. This book is theirs. Grateful to every one of them. www.amazon.com/Studies-Ever...
000
Benjamin P. Geisler @ben-geisler.com · 10/03/2026
Physical copy of 50 Studies Every Hospitalist Should Know arrived.. After years of transatlantic editing with Jeff & Kathy -starting from when we met at @massgeneralbrigham.bsky.social- the paperback is a different feeling! Now available from @oxunipress.bsky.social: www.amazon.com/Studies-Ever...
000
Benjamin P. Geisler @ben-geisler.com · 09/03/2026
When someone begins their sentence with "Strangely enough, ..." - it's often ends up not being that far-fetched...
000